{"id":"W4386319418","doi":"10.1016/j.bulcan.2023.06.009","title":"Real-world dostarlimab use in advanced/recurrent endometrial cancer in France","year":2023,"lang":"en","type":"article","venue":"Bulletin du Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Sierra Oncology; GlaxoSmithKline","keywords":"Medicine; Endometrial cancer; Expanded access; Clinical trial; Internal medicine; Cancer; Authorization; Randomized controlled trial; Cohort; Adverse effect; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004772218,0.0002687943,0.000560966,0.0009989062,0.0004079803,0.002065508,0.0003758755,0.0006717879,0.001777454],"category_scores_gemma":[0.008609941,0.0002264111,0.0005893548,0.001205464,0.0006015308,0.0005749133,0.0004746314,0.0005869256,0.0002997509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004937116,"about_ca_system_score_gemma":0.002517625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05064569,"about_ca_topic_score_gemma":0.03144427,"domain_scores_codex":[0.9943018,0.003087046,0.0004067526,0.0008396156,0.0009091942,0.0004555499],"domain_scores_gemma":[0.9910472,0.002951104,0.004150471,0.0003975676,0.0007844356,0.000669204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002219426,0.0002841478,0.9377621,0.0004655992,0.0005907693,0.001273875,0.00220687,0.002121165,0.001152971,0.0007948977,0.006228338,0.04489981],"study_design_scores_gemma":[0.000331009,0.001372399,0.9748836,0.0001564079,0.0001506139,0.001684965,0.001290504,0.001552421,0.0005488088,0.0001929719,0.0177567,0.00007958769],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856177,0.004376383,0.0007584626,0.001624954,0.00003259437,0.0001164644,0.004168298,0.00008026352,0.00322485],"genre_scores_gemma":[0.9966247,0.0007515641,0.0004207145,0.0004824864,0.00004673607,0.00006967481,0.001303324,0.00001395973,0.000286941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05064569,"threshold_uncertainty_score":0.1007017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03287550597304283,"score_gpt":0.3279943623960584,"score_spread":0.2951188564230156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}